Established 1999
     
8,000 companies from USA and India.  
   
Search over 25,500 news articles and 8,000 companies earnings    
 

Merrimack Pharmaceuticals Inc(MACK)

 
123Jump Rating:   Underwriters: J.P. Morgan
     
Status: Priced  
 
Address: One Kendall Square
Suite B7201, Cambridge
FiledDate: 2011-08-19
  Suite B7201, Cambridge
   
  MA 02139, US
Filed Price Range ($):
       
Telephone: 617-441-1000 Filed Offer Amount ($ Million): $0.00
       
Fax: 1-617-4911386 Shares Offered (Millions):
       
Websites: www.merrimackpharma.com Shares Outstanding (Millions):
       
Management: Gary L. Crocker - Chairman of the Board of Directors
IPO Date:
  Robert J. Mulroy - President, CEO and Director
   
  William A. Sullivan - CFO and Treasurer
Final Offer Price ($): $0.00
       
Industry: Pharmaceutical Preparations Final Offer Size (Millions of Shares): 0.00
       
Employees: 218 Final Offer Amount ($ Million): $0.00
       
Competitors: S-1 Forms:
     
   
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Product/Services Portfolio
 

 

Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.

350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries

Other Sites:
1999-2014 123jump.com. All rights reserved